Sentence examples similar to improvement in the end from inspiring English sources

The results show a significant improvement in the end-to-end parameters, including the end-to-end delay (22%) and jitter (80%), when compared with standards-based SNR approach.

Our results supporting a high-demand video application in the uplink stream show a significant improvement in the end-to-end quality of service parameters, including end-to-end delay (22%) and jitter (80%), when compared with a policy based on signal-to-noise-ratio information.

Hence, there are potentials for improvement in the end-of-life care that is provided by the GP co-operatives.

Note that these simulation results support the previously presented claim (for both outage probability and ergodic capacity analyses) that the use of channel phase resolution exceeding N = 3 bits/RS does not provide additional improvements in the end-to-end performance of our DBF architecture.

In March, a Commons Health Committee report called for vast improvements in the end-of-life care for people living in the UK and a 'better recording of what people want in their last days.' Yet, there's no bold proposal to make things better and, what's more, health and social services in the UK were badly cut during the last parliament and likely will be again during the next.

It is worth noting that a significantly greater percentage of onabotulinum toxin A-treated with respect to placebo-treated patients showed 50% or more improvement in the primary end point (mean headache days), both when the 12-week time point and the entire post-treatment period, from 4 to 12 weeks, were considered.

There was no improvement in the primary end point (walking speed) or in secondary measures of muscle function (2-minute walk test, work, power) in the glutamine group compared with placebo.

Clinical improvement in the second end point is somewhat lower in our results (74% in our study as opposed to 84.7% in the Hurst study).

- The weight of costs and side effects was not adequately compared with the modest and questionable improvement in the primary end points.

The addition of vandetanib to docetaxel showed a statistically significant improvement in the primary end point of progression-free survival (PFS) and in objective response rate (ORR), but not in overall survival (OS) [ 5].

The planned enrollment of 330 subjects provided a power of 80% to detect a 50% improvement in the primary end point at 12 months (from 40% in the PTA group to 60% in the DCB group) with a 1-sided type I error of 2.5%.